Dublin, Feb. 12, 2020 (GLOBE NEWSWIRE) -- The "Anastomosis Device Market by Product, Surgical Staplers (Manual, Powered), Surgical Sutures (Absorbable, Non-absorbable), and Surgical Sealants and Adhesives, Application (GI, CVD, Other), & End Users (Hospital, ASCs/Clinic) - Global Forecast to 2024" report has been added to ResearchAndMarkets.com's offering.
The global anastomosis devices market is projected to reach USD 2.9 billion by 2024 from an estimated USD 2.1 billion in 2019, at a CAGR of 7.2% during the forecast period.
The key factors driving the growth of this market include the increasing incidence of target diseases & the subsequent growth in the number of surgical procedures and growing demand for minimally invasive surgeries. However, the high cost of devices and extensive clinical data requirements for launching new products are expected to restrain the growth of this market during the forecast period.
By application, the gastrointestinal surgeries segment is expected to grow at the highest CAGR during the forecast period (2019-2024)
On the basis of application, the market is segmented into gastrointestinal surgeries, cardiovascular and thoracic surgeries, and other applications. The gastrointestinal surgeries segment commanded the largest share of the anastomosis devices market in 2018. The large share of this segment can be attributed to the rising incidence of gastrointestinal cancer and the extensive usage of anastomosis devices in these surgical procedures.
The Asia Pacific to witness the highest growth during the forecast period (2019-2024)
The Asia Pacific market is projected to register the highest growth during the forecast period. Factors such as the increasing number of hospitals, developing healthcare infrastructure, increasing healthcare expenditure, growing geriatric population, and the presence of a large patient population are driving the growth of the anastomosis devices market in the Asia Pacific.
Prominent players in the global anastomosis devices market include Johnson & Johnson (US), Medtronic plc (Ireland), B. Braun Melsungen AG (Germany), Smith & Nephew (UK), EndoEvolution LLC (US), CryoLife, Inc. (US), Becton, Dickinson, and Company (US), CONMED Corporation (US), Intuitive Surgical, Inc. (US), Boston Scientific Corporation (US), Baxter International, Inc. (US), Peters Surgical (France), Biosintex (Romania), and Meril Life Sciences (India).
Key Topics Covered
1 Introduction
2 Research Methodology
3 Executive Summary
4 Premium Insights
4.1 Anastomosis Devices: Market Overview
4.2 North America: Anastomosis Devices Market, By Type, 2018
4.3 Geographical Snapshot of the Anastomosis Devices Market
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increasing Target Disease Prevalence and Subsequent Growth in the Number of Surgical Procedures
5.2.1.2 Growing Demand for Minimally Invasive Surgeries
5.2.1.3 Technological Advancements
5.2.2 Restraints
5.2.2.1 High Cost of Devices and Extensive Clinical Data Requirements for Launching New Products
5.2.3 Opportunities
5.2.3.1 Growing Healthcare Markets in Emerging Economies
5.2.4 Challenges
5.2.4.1 Product Recalls
5.2.4.2 Dearth of Trained Professionals
6 Anastomosis Devices Market, By Product
6.1 Introduction
6.2 Surgical Staplers
6.2.1 Manual Surgical Staplers
6.2.1.1 Manual Surgical Staplers to Account the Largest Share of Market
6.2.2 Powered Surgical Staplers
6.2.2.1 Powered Surgical Staplers to Grow at Fastest Rate During the Forecast Period
6.3 Surgical Sutures
6.3.1 Absorbable Sutures
6.3.1.1 Synthetic Sutures
6.3.1.1.1 Polyglactin 910 Sutures
6.3.1.1.1.1 Polyglaction 910 to Grow at the Fastest Rate During the Forecast Period the Largest Share of Market
6.3.1.1.2 Poliglecaprone 25 Sutures
6.3.1.1.2.1 Growing Number of Gastrointestinal and Urological Surgical Procedures to Drive the Demand for Poliglecaprone 25 Sutures During the Forecast Period.
6.3.1.1.3 Polydioxanone Sutures
6.3.1.1.3.1 Superior Properties of Polydioxanone Sutures Compared With Other Sutures to Drive the Market for This Segment
6.3.1.1.4 Polyglycolic Acid Sutures
6.3.1.1.4.1 Increasing Number of Gynecological & Obstetric, Urological, and Gastroenterological Surgical Procedures to Drive the Market for Pga Sutures.
6.3.1.1.5 Other Synthetic Sutures
6.3.1.2 Natural Sutures
6.3.2 Non-Absorbable Sutures
6.3.2.1 Polypropylene Sutures
6.3.2.1.1 Polypropylene Sutures to Grow at the Fastest Rate During the Forecast Period.
6.3.2.2 Nylon Sutures
6.3.2.2.1 High Preference in Surgeries to Drive the Market During the Forecast Period.
6.3.2.3 Stainless Steel Sutures
6.3.2.3.1 Risk Associated With Stainless Steel Sutures to Restrain the Market Growth
6.3.2.4 Other Non-Absorbable Sutures
6.3.3 Automated Suturing Devices
6.3.3.1 Disposable Automated Suturing Devices
6.3.3.1.1 Cost-Effectiveness and Time-Efficiency of Disposable Automated Suturing Devices to Drive the Market
6.3.3.2 Reusable Automated Suturing Devices
6.3.3.2.1 Reusable Automated Suturing Devices to Drive at the Fastest Rate During the Forecast Period.
6.4 Surgical Sealants and Adhesives
6.4.1 Natural/Biological Surgical Sealants and Adhesives
6.4.1.1 Fibrin-Based Sealants & Adhesives
6.4.1.1.1 Increase in the Number of Surgical Procedures to Drive the Market
6.4.1.2 Collagen-Based Sealants and Adhesives
6.4.1.2.1 Risk Associated With Swelling of Tissues is Expected to Limit the Growth of This Market.
6.4.1.3 Albumin-Based Sealants and Adhesives
6.4.1.3.1 Albumin-Based Sealants and Adhesives to Grow at the Fastest Rate During the Forecast Period.
6.4.2 Synthetic and Semisynthetic Sealants and Adhesives
6.4.2.1 Peg Hydrogel-Based Sealants and Adhesives
6.4.2.1.1 Peg Hydrogel-Based Sealants and Adhesives Accounted for the Largest Share of This Market
6.4.2.2 Cyanoacrylate-Based Sealants and Adhesives
6.4.2.2.1 Risk of Infection and Various Complications to Restrain the Growth of This Market
6.4.2.3 Urethane-Based Sealants and Adhesives
6.4.2.3.1 High Wettability Properties of Urethane Based Adhesives to Drive the Market.
6.4.2.4 Other Synthetic and Semisynthetic Sealants and Adhesives
7 Anastomosis Devices Market, By Application
7.1 Introduction
7.2 Gastrointestinal Surgeries
7.2.1 Gastrointestinal Surgeries to Dominate the Anastomosis Market
7.3 Cardiovascular & Thoracic Surgeries
7.3.1 Rising Incidence of Cardiovascular Disorders Will Drive the Market
7.4 Other Applications
8 Anastomosis Devices Market, By End User
8.1 Introduction
8.2 Hospitals
8.2.1 Hospitals Dominate the End-User Market
8.3 Ambulatory Surgery Centers & Clinics
8.3.1 Increasing Number of Centers Will Drive Market Growth
9 Anastomosis Devices Market, By Region
9.1 Introduction
9.2 North America
9.2.1 US
9.2.1.1 The US is the Largest Market for Anastomosis Devices Due to the High Healthcare Spending in the Country
9.2.2 Canada
9.2.2.1 Growing Number of Organ Transplants to Drive the Anastomosis Devices Market in Canada
9.3 Europe
9.3.1 Germany
9.3.1.1 Germany to Dominate the European Market for Anastomosis Devices During the Forecast Period
9.3.2 UK
9.3.2.1 Growing Number of Surgical Procedures to Drive Market Growth in the UK
9.3.3 France
9.3.3.1 Favorable Health Insurance System to Drive the Market for Anastomosis Devices in France
9.3.4 Italy
9.3.4.1 Growing Healthcare Expenditure to Support the Market for Anastomosis Devices in Italy
9.3.5 Spain
9.3.5.1 The High Cost of Surgical Procedures to Restrain the Growth of the Anastomosis Devices Market in Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.1.1 Large Patient Population and Healthcare Infrastructure Improvements to Drive Market Growth in China
9.4.2 India
9.4.2.1 Healthcare Infrastructure Improvements and Implementation of Favorable Government Initiatives to Support Market Growth in India
9.4.3 Japan
9.4.3.1 Supportive Reimbursement Policies to Drive Market Growth in Japan
9.4.4 Australia
9.4.4.1 High Prevalence of Cancer to Drive the Demand for Anastomosis Devices in Australia
9.4.5 Rest of Asia Pacific
9.5 Rest of the World
9.5.1 Latin America
9.5.1.1 Increasing Purchasing Power and Healthcare Affordability Will Favor Market Growth in Latin America
9.5.2 Middle East & Africa
9.5.2.1 Infrastructural Developments to Drive the Market for Anastomosis Devices in the MEA
10 Competitive Landscape
10.1 Introduction
10.2 Market Share Analysis
10.3 Competitive Leadership Mapping (Overall Market) (2018)
10.3.1 Visionary Leaders
10.3.2 Innovators
10.3.3 Dynamic Differentiators
10.3.4 Emerging Companies
10.4 Competitive Scenario
10.4.1 Key Developments in the Anastomosis Devices Market
10.4.2 Key Product Launches and Approvals
10.4.3 Key Acquisitions
10.4.4 Key Expansions
11 Company Profiles
11.1 Medtronic PLC
11.2 Johnson & Johnson
11.3 B. Braun Melsungen AG
11.4 Smith & Nephew PLC
11.5 Endoevolution, LLC
11.6 Cryolife, Inc.
11.7 Becton, Dickinson and Company
11.8 CONMED Corporation
11.9 Intuitive Surgical, Inc.
11.10 Boston Scientific Corporation
11.11 Baxter International, Inc.
11.12 Peters Surgical
11.13 Biosintex
11.14 Meril Life Sciences Pvt. Ltd.
11.15 Internacional Farmacutica S.A. de C.V.
For more information about this report visit https://www.researchandmarkets.com/r/ao9ziz
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900